SYSTEMIC LUPUS ERYTHEMATOSUS (WITH AND WITHOUT NEPHRITIS)

Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS (WITH AND WITHOUT NEPHRITIS) explained in plain language.

Never miss a new study

Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS (WITH AND WITHOUT NEPHRITIS) trials appear

Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (WITH AND WITHOUT NEPHRITIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test 'Living Drug' to reset the immune system in lupus and related diseases

Disease control Recruiting now

This is a first-in-human study testing the safety and early effectiveness of a new type of cell therapy called ALLO-329 in adults with severe autoimmune diseases like lupus, myositis, and scleroderma. The therapy involves giving patients specially engineered immune cells (CAR T c…

Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (WITH AND WITHOUT NEPHRITIS)

Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

SYSTEMIC LUPUS ERYTHEMATOSUS (WITH AND WITHOUT NEPHRITIS)

Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS (WITH AND WITHOUT NEPHRITIS) trials appear

Scientists test 'Living Drug' to reset the immune system in lupus and related diseases